EC Number |
Inhibitors |
Structure |
---|
1.1.1.95 | (2,3-dihydro-1H-benzotriazol-1-yl)(4-phenylpiperazin-1-yl)methanone |
0.1 mM, 37% inhibition |
|
1.1.1.95 | (3,4-dichlorophenyl)(morpholin-4-yl)methanethione |
0.1 mM, 96% inhibition |
|
1.1.1.95 | (3R)-N-(4,6-dimethylpyridin-2-yl)-3-methyl-4-[[4-(trifluoromethyl)phenyl]methyl]piperazine-1-carbothioamide |
- |
|
1.1.1.95 | (3R,5S)-N-(4,6-dimethylpyridin-2-yl)-3,5-dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]piperazine-1-carbothioamide |
- |
|
1.1.1.95 | (3S)-N-(4,6-dimethylpyridin-2-yl)-3-methyl-4-[[4-(trifluoromethyl)phenyl]methyl]piperazine-1-carbothioamide |
- |
|
1.1.1.95 | (4-methylpyridin-2-yl)[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methanethione |
- |
|
1.1.1.95 | (NH4)2SO4 |
inhibitory effect on NADPH-dependent 3-phosphohydroxypyruvate reduction |
|
1.1.1.95 | (R)-2-amino-1-propanol |
slightly |
|
1.1.1.95 | 1-(2,4-dichlorophenyl)-2-morpholino-2-thioxoethan-1-one |
- |
|
1.1.1.95 | 1-(2-bromophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one |
- |
|